Moreover, CCR9 is highly expressed in malignancies, such as lung cancer [15], breast cancer [16,17], ovarian cancer [18], melanoma [19,20], and T-cell acute lymphoblastic leukemia (T-ALL) [21]. This evidence concerns the gene CCR9 and T-cell acute lymphoblastic leukemia.